Ann: Notice of Annual General Meeting/Proxy Form , page-9

re: Ann: Notice of Annual General Meeting/Pro... As stated a long time back, a collaboration with PNO will do much more for PNO's shareprice than for ours.


The fact that 15% dilution is not sufficient to bring our own program online is concerning and clearly indicates that our own program is not developed on the heels of a successful partner program.


Many companies do adjust their CR abilities ( see PEN tonight in its AGM meeting ann ) if they had raised funds within the FY in question.
OBJ though attempts to get SH approval for an additional 10% of dilution which would bring us to a possible 250mil shares at possibly 1 cents now, resulting in 2.5 mil additional cash?
In combination with our existing cash reserves, that would create a maximum financial support of 5 mil towards our own program.


Would we end up using PNO's thermalife extension sports gel ( which interestingly uses deep heat components and is not a peptide gel ), costs for bringing that to market would be relatively cheap, due to low or nearly not existing regulatory hurdles, keeping deep heats long sales record in mind for the compound and thermalife's 18 years of no complications for the parent pipeline identity.



If many had wondered why our shareprice has been driven down lately, I assume we do have the answer as some in the market anticipated a CR.